ProCE Banner Events

Share

Spinal Muscular Atrophy: Optimizing the Management of Adults in the Era of Disease-Modifying Therapies

Unlock the latest breakthroughs in spinal muscular atrophy (SMA) care! Join us for an expert-led discussion on disease-modifying therapies, personalized treatment approaches, and patient engagement strategies. Elevate your practice and stay ahead in SMA management.

Physicians: maximum of 1.00 AMA PRA Category 1 Credit™

Who Should Attend

The intended audience for this educational initiative is neurologists who manage patients with spinal muscular atrophy.

Time and location

Thursday, May 09, 2024

6:30 PM - 7:30 PM Eastern Time (ET)

Virtual

Faculty
Perry Shieh, MD, PhD

Professor (Health Sciences)
Departments of Neurology and Pediatrics
David Geffen School of Medicine at UCLA
University of California, Los Angeles
Los Angeles, California

Agenda

  • SMA overview, SMA type IV  
  • Disease burden, clinical and psychosocial impact
    • Adult specific factors to consider – occupational/career, family planning 
  • Treatment options   
    • Safety and efficacy of available and emerging treatments for adults with SMA  
      • Risdiplam, nusinersen 
      • Clinical updates of note 
    • Psychosocial support for patients with SMA 
  • Factors to consider when developing/modifying treatment plans   
    • Goals, disease progression 
    • Patient factors/preferences 
    • Patient engagement: How to foster this (shared decision-making, communication strategies) 
    • Case example(s)

CME/CE Info

Goal Statement
Neurologists need to modify their clinical approach to provide individualized care within the context of new treatments. The number of adults with SMA is expected to continue to grow, and thus, a greater need exists for clinicians to improve their provision of age-appropriate care and ensure adults benefit from therapeutic advances. This educational initiative will provide targeted, clear, and concise information that would help neurologists provide optimal, individualized care to their adult patients with SMA.

Target Audience
The intended audience for this educational initiative is neurologists who manage patients with spinal muscular atrophy. 

Learning Objectives:

  • Discuss the unique clinical issues and psychosocial needs faced by adults with SMA
  • Assess the latest safety and efficacy data of available and emerging disease-modifying therapies for SMA in adults
  • Integrate available disease-modifying therapies for SMA into individualized, evidence-based treatment plans
  • Apply effective communication strategies to engage patients in shared decision making and reach management decisions that meet their individual needs

Accreditation

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Clinical Care Options, LLC (CCO) and Cure SMA. Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABMS MOC RECOGNITION STATEMENT
Through the American Board of Medical Specialties (“ABMS”) ongoing commitment to increase access to practice relevant Continuing Certification Activities through the ABMS Continuing Certification Directory, Spinal Muscular Atrophy Optimizing the Management of Adults in the Era of Disease-Modifying Therapies has met the requirements as a Lifelong Learning CME Activity (apply toward general CME requirement) for the following ABMS Member Boards: 

ABMS Lifelong Learning CME Activity
Psychiatry and Neurology

Disclosure of Conflicts of Interest 
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by Clinical Care Options, LLC, in partnership with Cure SMA

Supported by educational grants from Biogen and Genentech, a member of the Roche Group.

Contact Information

Contact Clinical Care Options

For customer support please click here.

Mailing Address:


Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Additional Information

There are no fees required to participate in this activity.

Americans With Disabilities Act 
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact Customer Support prior to the live event.